Delivery Order SPE2DB20D7059-SPE2DB24FPYJ3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,134.63 firm fixed-price delivery order is for the supply of 4,566,817,731 units of the drug Atomoxetine HCL 25 mg capsules. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Atomoxetine HCL 40 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 30, 2022 with a ceiling value of $2,114.66. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of March 31, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, which is a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a firm fixed-price delivery order with a ceiling value of $3,287.50 and an ultimate completion date of September 19, 2023....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,266.32, is for the delivery of 18 mg capsules of the medication atomoxetine hydrochloride in quantities of 30. The contract is a firm fixed price delivery order with a period of performance through March 27, 2024. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atomoxetine HCL 18 mg capsules, with a ceiling value of $2,205.42 and a performance period extending to May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,888,754 units of Atomoxetine HCL 18 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $4,381.89, has a firm fixed price and an ultimate completion date of August 22, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the supply of 10 mg capsules of the pharmaceutical drug Atomoxetine HCL, with a ceiling value of $1,567.02. The contract is a firm fixed price delivery order, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Atomoxetine HCL 18 mg capsules. The award, with a ceiling value of $1,265.40, is structured as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,038.83 firm fixed price delivery order is for the supply of the prescription medication atomoxetine hydrochloride 25mg capsules. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,080.97, is a delivery order contract for the supply of 4566861402 - Atomoxetine HCL 40 MG Capsule 30S. The contract has a completion date of January 8, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FPYJ3Delivery Order
This federal contract award is for the delivery of Atomoxetine HCl 10 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract has a firm fixed price structure, a potential value of $1,626.20, and a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/31/24 |